| Old Articles: <Older 45651-45660 Newer> |
|---|
 |
The Motley Fool
November 29, 2010
Dan Dzombak |
Are These Utility Firms Creating Value? What Economic Value Added momentum shows us about the folks running these utility companies.   |
The Motley Fool
November 29, 2010
Jeremy Phillips |
Time to Sell Tesoro? Tesoro is clearly having issues maintaining its gross margin, which tends to dictate a company's overall profitability. |
The Motley Fool
November 29, 2010
Seth Jayson |
Don't Get Too Worked Up Over PotashCorp's Earnings With questionable cash flows amounting to only 6.5% of operating cash flow, PotashCorp's cash flows look clean. |
The Motley Fool
November 29, 2010
Rex Moore |
Rising Star Buy: Coca-Cola The syrup maker edges out Mr. Softy and other top competitors. |
The Motley Fool
November 29, 2010 |
Rising Star Buy: Imation Analyst Dan Dzombak recommends a buy of Imation. |
The Motley Fool
November 29, 2010
Seth Jayson |
Check This to Find Out Whether Orthovita Is Going to Bomb For the last fully reported fiscal quarter, Orthovita's year-over-year revenue grew 4.6%, and its AR grew 9.2%. That looks OK. |
The Motley Fool
November 29, 2010
Tim Beyers |
CSX: Not Quite Priced to Move But this train might leave the station soon. |
The Motley Fool
November 29, 2010
Brian Orelli |
There's Still Only One Merck KGaA's oral MS drug delay is Novartis' gain. |
The Motley Fool
November 29, 2010
Dan Dzombak |
Are These Food & Beverage Companies Creating Value? What Economic Value Added momentum shows us about the folks running these four food & beverage companies. |
The Motley Fool
November 29, 2010
Travis Hoium |
Protalix BioTherapeutics Shares Popped: What You Need to Know Shares of biopharmaceutical company Protalix BioTherapeutics jumped 10% this morning after the company announced a European application for taliglucerase alfa. |
| <Older 45651-45660 Newer> Return to current articles. |
